AIM Vaccine Co., Ltd. (HKG: 6660)
4.190
-0.090 (-2.10%)
Sep 9, 2024, 11:19 AM HKT
AIM Vaccine Revenue
AIM Vaccine had revenue of 537.18M CNY in the half year ending June 30, 2024, a decrease of -9.19%. This brings the company's revenue in the last twelve months to 1.18B, down -2.37% year-over-year. In the year 2023, AIM Vaccine had annual revenue of 1.19B, down -6.06%.
Revenue (ttm)
1.18B CNY
Revenue Growth
-2.37%
P/S Ratio
3.78
Revenue / Employee
729.17K CNY
Employees
1,624
Market Cap
4.81B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.19B | -76.61M | -6.06% |
Dec 31, 2022 | 1.26B | -306.06M | -19.49% |
Dec 31, 2021 | 1.57B | -67.84M | -4.14% |
Dec 31, 2020 | 1.64B | 686.32M | 72.12% |
Dec 31, 2019 | 951.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition